Summary
CVS Health Corporation has announced a significant debt offering, raising approximately $5.94 billion through the issuance of various senior notes. This move is primarily to fund its previously announced acquisition of Oak Street Health, Inc. The company has entered into an Underwriting Agreement to sell $1.5 billion in 5.000% Senior Notes due 2026, $1.5 billion in 5.125% Senior Notes due 2030, $1.75 billion in 5.250% Senior Notes due 2033, and $1.25 billion in 5.625% Senior Notes due 2053. This substantial debt financing is a key step in completing the acquisition of Oak Street Health, which is expected to be a significant strategic move for CVS Health. Investors should note that while this financing strengthens CVS Health's liquidity for the acquisition, it also increases the company's overall debt burden. The successful closing of the notes sale is expected on February 21, 2023, subject to customary closing conditions.
Key Highlights
- 1CVS Health priced a total of $5.94 billion in senior notes across four different maturity dates (2026, 2030, 2033, and 2053).
- 2The notes carry coupon rates ranging from 5.000% to 5.625%, reflecting current market conditions for long-term debt.
- 3The net proceeds from this offering are approximately $5,940,824,000 after deducting underwriter fees and expenses.
- 4This debt issuance is intended to fund the previously announced acquisition of Oak Street Health, Inc.
- 5The closing of the notes sale is anticipated on February 21, 2023, pending satisfaction of closing conditions.
- 6The offering was conducted under CVS Health's existing Form S-3ASR registration statement.
- 7Key underwriters for the offering include BofA Securities, Inc., Barclays Capital Inc., and J.P. Morgan Securities LLC.